Merial Pioneers PURE VAX ™ Ferret Distemper Vaccine
Responds to Need for Ferret Vaccine with Innovative Recombinant Technology
October 9, 2001
DULUTH, Ga. Merial, the world's leading animal health company, launches PUREVAX™ Ferret Distemper Vaccine, an innovative vaccine to control canine distemper in ferrets. With the U.S. Department of Agriculture's approval of this vaccine, Merial becomes the first animal health company to offer a complete line of vaccines for ferrets.
This vaccine was developed with Merials state-of-the-art recombinant canarypox vectored technology, in which only the portion of the virus or bacteria needed to stimulate an immune response is used. The only animal health company with the patented canarypox vectored technology, Merial first used it in its PUREVAX rabies vaccines for cats and in the RECOMBITEK® distemper vaccines for dogs.
PUREVAX Ferret Distemper Vaccine is a pure and effective vaccine, which does not contain adjuvants or the whole canine distemper virus, and has a unique safety profile that eliminates the potential risks of post-vaccination encephalitis and immunosuppression.
Distemper is considered a serious viral disease in ferrets, with mortality rates approaching 100 percent. Currently, treatment of ferret distemper consists of supportive therapy, fluids and antibiotics, which are ultimately of little value. "With more than 10 million ferrets in U.S. households, the key is to prevent distemper in ferrets," says Zack Mills, D.V.M., director, vaccine marketing, companion animal global enterprise at Merial.
"Merial saw an unmet need for this vaccine and worked to provide an innovative solution, in keeping with company's mission of enhancing the health and well-being of animals," Mills says. "This vaccine builds on the companys leadership in vaccine development."
The goal of recombinant technology in immunology is to produce vaccines that afford unsurpassed safety, effectiveness and convenience while working to reduce or eliminate the drawbacks that have been associated with conventional vaccines, such as reversion to virulence. Merial has been using recombinant technology to develop products since 1996.
For more information about Merial, visit www.merial.com.
Merial is the only animal health company to offer a complete line of vaccines for ferrets: PUREVAX™ Ferret Distemper Vaccine and IMRAB® 3.
PUREVAX Ferret Distemper Vaccine
For further information please contact:
™PUREVAX is a trademark and RECOMBITEK® is a registered trademark of Merial, Duluth, Ga.